138 related articles for article (PubMed ID: 6932995)
1. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
[TBL] [Abstract][Full Text] [Related]
2. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
[TBL] [Abstract][Full Text] [Related]
3. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
[TBL] [Abstract][Full Text] [Related]
4. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
[TBL] [Abstract][Full Text] [Related]
5. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
[TBL] [Abstract][Full Text] [Related]
6. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
[No Abstract] [Full Text] [Related]
7. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
[TBL] [Abstract][Full Text] [Related]
8. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Lauer SJ; Camitta BM; Leventhal BG; Mahoney DH; Shuster JJ; Adair S; Casper JT; Civin CI; Graham M; Kiefer G
Cancer; 1993 May; 71(9):2854-61. PubMed ID: 8467463
[TBL] [Abstract][Full Text] [Related]
9. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
[No Abstract] [Full Text] [Related]
10. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
[TBL] [Abstract][Full Text] [Related]
11. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia.
Lauer SJ; Pinkel D; Buchanan GR; Sartain P; Cornet JM; Krance R; Borella LD; Casper JT; Kun LE; Hoffman RG
Cancer; 1987 Nov; 60(10):2366-71. PubMed ID: 3499211
[TBL] [Abstract][Full Text] [Related]
12. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
[TBL] [Abstract][Full Text] [Related]
13. [VP 16-213 in the treatment of acute leukemia in childhood].
Esumi N; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy.
Lay HN; Ekert H; Colebatch JH
Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044
[TBL] [Abstract][Full Text] [Related]
15. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
16. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
[No Abstract] [Full Text] [Related]
17. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
18. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
[TBL] [Abstract][Full Text] [Related]
19. Etoposide and cytosine arabinoside combination chemotherapy for refractory acute lymphocytic leukemia in childhood.
Esumi N; Todo S; Arakawa S; Imashuku S
J Clin Oncol; 1986 Jul; 4(7):1089-93. PubMed ID: 3459812
[TBL] [Abstract][Full Text] [Related]
20. Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia.
Kimball JC; Herson J; Sullivan MP
Cancer; 1980 Sep; 46(5):1093-7. PubMed ID: 6938300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
